COLLIN BAGGETT: Open Payments
NPI 1548933773 · HENDERSONVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 134 payments from 17 companies in 2025. Trend: 2023 $1,911 · 2024 $2,137 · 2025 $2,637
Food & beverage: $2,637
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 30 | $545 |
| AstraZeneca Pharmaceuticals LP | 27 | $503 |
| Insmed, Inc. | 17 | $292 |
| Grifols USA, LLC | 11 | $264 |
| Regeneron Healthcare Solutions, Inc. | 9 | $203 |
| GENZYME CORPORATION | 8 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $152 |
| Viatris Specialty LLC | 7 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Verona Pharma, Inc. | 2 | $61 |
Products named: DUPIXENT, NUCALA, Arikayce, Prolastin-C Liquid, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA, YUPELRI.
Industry payments across TN — which companies pay providers there.
